VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹28 Cr | ₹18 Cr | ₹60 Cr | ₹58 Cr | ₹46 Cr |
What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹28 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹46 Cr |
How is Total Non-Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹28 Cr | 52.57 | |
| Mar2025 | ₹18 Cr | -69.12 | |
| Mar2024 | ₹60 Cr | 2.89 | |
| Mar2023 | ₹58 Cr | 26.60 | |
| Mar2022 | ₹46 Cr | - | |
Compare Total Non-Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,220.4 Cr | 6.1% | -13.4% | 210% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 6.1% |
-13.4% |
210% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses